Since the beginning of the pandemic, researchers and laboratories around the world have mobilised to develop effective vaccines against COVID-19.The first vaccine against SARS-CoV-2 to be authorised by the European Medicines Agenc

On February 5, 2018 the French National Security Agency for Medicines and Health Products (ANSM) published an updated version of its Good Pharmacovigilance Practices (GVP). France GVP were first published on 2005 and then updated